Market Cap 256.64M P/E - EPS this Y - Ern Qtrly Grth -
Income -20.04M Forward P/E - EPS next Y - 50D Avg Chg 59.00%
Sales 3.73M PEG - EPS past 5Y - 200D Avg Chg 102.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -61.00%
Recommedations - Quick Ratio 0.04 Shares Outstanding 1.04B 52W Low Chg 604.00%
Insider Own 66.39% ROA - Shares Float 331.76M Beta 7.88
Inst Own - ROE - Shares Shorted/Prior -/- Price 0.25
Gross Margin 87.47% Profit Margin - Avg. Volume 6,822,401 Target Price -
Oper. Margin -534.29% Earnings - Volume 5,798,761 Change 22.61%
BIOTECH PROD SVCS & RESEARCH IN News
05/11/21 Organicell Receives Approval in Pakistan for the Use of Zofin™ for Compassionate Grounds for COVID-19
05/04/21 Organicell Begins Up-Listing Process On NASDAQ Exchange
04/28/21 Organicell Announces Positive Results of Initial COVID-19 Zofin™ Patient Trial in India and Trial Expansion
04/22/21 Organicell Completes Enrollment for its Expanded Access Trial to Treat COVID-19 Patients with Zofin™
04/21/21 Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In The Treatment Of Osteoarthritis
04/14/21 Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential
03/23/21 Organicell and The Centers for Disease Control and Prevention Enter Into Agreement To Conduct Research on Influenza Viruses of Pandemic Potential
06:30 AM ‘Frontiers in Medicine’ Publishes Organicell’s Case Report Demonstrating the Use of Zofin™ in the Treatment of COVID-19 Patients
01/28/21 Organicell Announces FDA Approval of IND Application for the Use of Zofin™ in the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
01/12/21 The Forgotten Ones. Will Long-Haulers Be the Next Public Health Crisis?
12/29/20 Organicell Regenerative Medicine and Its Investigational Therapeutic Zofin™ Featured in Two National Publications Examining Potential Therapies for COVID-19 Long-Haulers
12/22/20 Organicell Regenerative Medicine, Inc. Becomes Current with SEC Reporting Requirements
09:12 AM CORRECTING and REPLACING Organicell Announces Additional Site for Phase I/II Clinical Trial of Zofin™ for Treatment of COVID-19
11/12/20 Organicell Provides Update on Its COVID-19 Clinical Trial Using ZofinTM
10/20/20 Organicell Partners with Regenerative Care Network to Study Potential Therapeutic Benefits of Zofin™ for Patients with Heart Failure
09/29/20 FDA Grants Organicell Expanded Access to Treat COVID-19 Patients with Zofin™
09/02/20 Three New COVID-19 Patients Treated with Zofin™ Report Improvement
08/20/20 First Reported "Long-Hauler" Post COVID-19 Patient Treated with Zofin™ Produces Excellent Preliminary Results
06:00 AM Organicell Phase I/II Clinical Trial Update

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19. Zofin contains approximately 300 growth factors, cytokines, chemokines, and 102 unique microRNAs, as well as other exosomes/nanoparticles derived from perinatal tissues. It also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. Organicell Regenerative Medicine, Inc. has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.

BPSR Chatroom

User Image indaknow Posted - 48 minutes ago

$BPSR https://ichgcp.net/clinical-trials-registry/NCT04384445 so US trials are set to finish in June as well. That coupled with India results and likely Pakistan is going to send this on a parabolic trajectory I hope.

User Image alpine2001 Posted - 53 minutes ago

$BPSR charts is ready to increase tomorrow. ⬆️💰

User Image WaynesCaddy Posted - 2 hours ago

$BPSR legally can’t spell it out but I think we all have a pretty good grasp on what’s in store within the next 3 days.

User Image HoldHuck Posted - 3 hours ago

$BPSR I'd be very surprised if there wasn't news tomorrow, Thursday, or Friday morning coordinated with ISEV 2021.

User Image tangos68 Posted - 3 hours ago

$BPSR Good rebound and PR of other phases still pending. We might se a breakthrough soon. It was good to grab some discounted shares this morning.

User Image RobAnt Posted - 3 hours ago

$POAI We are just warming up! $BNGO, $SOS,$BPSR are all runners too!

User Image Juice321AA Posted - 4 hours ago

$BPSR finished +23.33%

User Image WaynesCaddy Posted - 4 hours ago

$BPSR you mean the stock went up 20% after all of those share sells? Who could have predicted this?

User Image Connorcg Posted - 4 hours ago

$BPSR Possibly reversed the downward trend today. We need a green day tomorrow as confirmation.

User Image alpine2001 Posted - 4 hours ago

$GGII , $0.15 tomorrow. $BPSR $0.30-$0.35 tomorrow. $INCC increasing too! $EEGI adding dips. Congratulations family 🎉

User Image tjh2161 Posted - 4 hours ago

$BPSR True Power Hour!

User Image alpine2001 Posted - 4 hours ago

$BPSR asking $0.2479

User Image iBio_GlaisterPIT Posted - 4 hours ago

$BPSR $0.245 is where we are

User Image alpine2001 Posted - 4 hours ago

$BPSR adding now to close strong

User Image JoeyDeNiro Posted - 4 hours ago

$BPSR now holding over 679k shares

User Image ray250 Posted - 4 hours ago

$BPSR .25 close coming slap

User Image alpine2001 Posted - 4 hours ago

$BPSR let’s close at $0.25 and opening $0.30 🥂

User Image alpine2001 Posted - 4 hours ago

$GVSI we are running $BPSR

User Image alpine2001 Posted - 4 hours ago

$BPSR 12 minutes more to close at $0.30

User Image Scoops1212 Posted - 4 hours ago

$BPSR a lot of big predictions going on right now. The stock is currently up a penny from open. Understand this could be a cash pump and dump right in front of us again. I’m seeing predictions of 30 cents at close already. Let’s see how it closes and go from there. God Bless

User Image ray250 Posted - 4 hours ago

$BPSR .25 close coming add here gap tomorrow morning

User Image alpine2001 Posted - 4 hours ago

$BPSR $0.22 support. Let’s add to close at $0.25 . Tomorrow $0.30

User Image alpine2001 Posted - 4 hours ago

$AMZN trow your money with $BPSR anual meeting tomorrow and want to up list on Nasdaq. Good luck to us

User Image Kylejc28 Posted - 4 hours ago

$AMC will close at $13.98 again today but will go to $15.75 AH! Check out $BPSR big things coming in the next few weeks, covid treatment trial in India almost complete!

User Image alpine2001 Posted - 4 hours ago

$BPSR ⬆️💰💰💰from now.

User Image JerryTrades Posted - 4 hours ago

$BPSR Didn't quite make that .16. I think The low was .1708 lol. So when I bid low I generally go a bit higher than my lowest guess. The algos and day traders are always a step ahead. Glad to see a potential reversal here.

User Image alpine2001 Posted - 4 hours ago

$BPSR let’s close at $0.30 every one. If you’re holding post too

User Image skk777 Posted - 4 hours ago

$BPSR it’s crazy what a little volume can do here. When we get big news and the volume rises accordingly, this thing is gone....IMO

User Image alpine2001 Posted - 4 hours ago

$AMC we are running , conference tomorrow. $BPSR look at the charts

User Image alpine2001 Posted - 4 hours ago

@Mr_Philosopher $BPSR we are running. Where are you

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own
BOTHWELL IAN T Chief Financi.. Chief Financial Officer May 17, 9:45 PM Sell 0.23 175,000 40,250 149,570,000
Mitrani Albert President President May 17, 9:45 PM Sell 0.23 175,000 40,250 168,400,190
MITRANI MARIA INES Chief Science.. Chief Science Officer May 17, 9:45 PM Sell 0.23 175,000 40,250 118,205,000
Shapiro George Craig Chief Medical.. Chief Medical Officer May 17, 9:45 PM Sell 0.24 175,100 42,024 81,869,900
Mitrani Albert President President May 12, 9:45 PM Sell 0.29 175,000 50,750 168,575,190
BOTHWELL IAN T Chief Financi.. Chief Financial Officer May 12, 9:45 PM Sell 0.3 150,000 45,000 149,745,000
MITRANI MARIA INES Chief Science.. Chief Science Officer May 12, 9:45 PM Sell 0.3 175,000 52,500 118,380,000
Shapiro George Craig Chief Medical.. Chief Medical Officer May 12, 9:45 PM Sell 0.29 150,100 43,529 82,045,000
Mitrani Albert President President May 7, 9:45 PM Sell 0.27 205,000 55,350 168,750,190